Cellarity pricing
No price exists because there is no product for sale. Cellarity monetizes through its own pipeline and through partnered discovery, so the commercially meaningful disclosures at this stage are capital and deals. A $123 million Series B was raised in 2021, and the investor base is named as Flagship Pioneering, Baupost Group, BlackRock, Pictet, Hanwha Impact and Kyowa Kirin.
How Cellarity pricing works
- Pricing model
- Not applicable. Clinical stage therapeutics developer, funded by venture capital with revenue potential through partnering and future product sales rather than through software licensing.
- Implementation
- Not applicable. No customer deployment exists.
- Business associate agreement
- Not applicable. No covered entity customers and no business associate relationship, as the company develops its own therapeutics rather than supplying software or services to providers.
The metabolic dysfunction associated steatohepatitis program is partnered with Novo Nordisk and the inflammatory bowel disease program with Pioneering Medicines. No terms, upfront payments, milestone structure or royalty arrangements are disclosed for either, which is normal for this category and does mean the economic significance of the partnerships cannot be assessed from public material.
No cumulative funding total more recent than the 2021 Series B appears on the estate, including in the corporate outlook published on 8 January 2026, which sets out clinical and preclinical milestones in detail but no financial position. Two platform assets are published free rather than licensed: the ToxPredictor model with its validation data at dilimap.org, and three single cell datasets released with the Science 2025 paper.
Cellarity pricing against its alternatives
Published prices for Cellarity and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- CCellarityNot applicable
- DDeep GenomicsNo published price
- IImmunaiNo published price
- TTerray TherapeuticsNot applicable
- EEikon TherapeuticsNot applicable
- VValo HealthNo published price
- VVerge LabsPartnership structured, no list pricing
- EEnvedaNot applicable
- PPostEraNo published price
Cellarity pricing, answered
How much does Cellarity cost?
Cellarity does not publish a price. Cellarity monetizes through its own pipeline and through partnered discovery, so the commercially meaningful disclosures at this stage are capital and deals. A $123 million Series B was raised in 2021, and the investor base is named as Flagship Pioneering, Baupost Group, BlackRock, Pictet, Hanwha Impact and Kyowa Kirin.
Does Cellarity offer a business associate agreement?
Not applicable. No covered entity customers and no business associate relationship, as the company develops its own therapeutics rather than supplying software or services to providers.